Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab Optimization in HER2+ Breast Cancer
NCT00637325Phase 3Unknown
- Sponsor
- Regione Lombardia
- Start
- Nov 2007
- Primary completion
- May 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Regione Lombardia. Status: unknown.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00637325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637325.